Table 3.
Adjusted odds ratios (aOR) of in‐hospital clinical outcomes in patients with one extracardiac vascular bed involvement (stratified by involved organ site)
| Clinical outcomes | Cerebrovascular disease | Renovascular disease | Aortic disease | Peripheral artery disease | ||||
|---|---|---|---|---|---|---|---|---|
| aOR [95% CI] | p‐value | aOR [95% CI] | p‐value | aOR [95% CI] | p‐value | aOR [95% CI] | p‐value | |
| Mortality | 1.15 [1.10–1.19] | <0.001 | 1.09 [0.91–1.32] | 0.340 | 0.95 [0.87–1.03] | 0.212 | 1.48 [1.40–1.56] | <0.001 |
| MACCE | 1.54 [1.50–1.59] | <0.001 | 1.30 [1.13–1.49] | <0.001 | 1.09 [1.02–1.16] | 0.010 | 1.34 [1.28–1.40] | <0.001 |
| Acute ischemic stroke | 2.79 [2.67–2.91] | <0.001 | 1.87 [1.49–2.34] | <0.001 | 1.32 [1.18–1.48] | <0.001 | 1.35 [1.24–1.47] | <0.001 |
| Major bleeding | 1.11 [1.05–1.16] | <0.001 | 1.57 [1.31–1.87] | <0.001 | 1.14 [1.04–1.24] | 0.005 | 1.28 [1.21–1.36] | <0.001 |
Note: Multivariable analysis – the following variables were adjusted for: age, sex, weekend admission, hospital bed size, hospital location/teaching status, hospital region, primary expected payer, dementia, diabetes, dyslipidaemia, smoking, heart failure, atrial fibrillation/flutter, thrombocytopaenia, hypertension, anemia, chronic lung disease, coagulopathy, liver disease, chronic kidney disease, metastatic disease, valvular heart disease, cardiogenic shock, VT, VF, PCI indication, previous myocardial infarction, previous PCI, and previous coronary artery bypass grafting.
Abbreviations: aOR, adjusted odds ratios; CI, confidence interval; MACCE, major adverse cardiac and cerebrovascular events (composite of mortality, acute stroke, and reinfarction).
*Reference group: group with no extracardiac vascular involvement.